
ROSSI EMANUELA
Pubblicazioni
Cristoferi, L., D'Amato, D., Maino, C., Bernasconi, D., Dinelli, M., Malandrin, S., et al. (2026). Prospective, randomised, placebo-controlled, phase 2 clinical trial assessing the efficacy and safety of oral vancomycin in patients with primary sclerosing cholangitis with/out inflammatory bowel disease in Italy: study protocol of VanC-IT trial. BMJ OPEN, 16(1) [10.1136/bmjopen-2025-106630]. Dettaglio
Turati, M., Tosoni, D., Benedettini, E., Albanese, F., Alessandro, C., Rossi, E., et al. (2025). Hamstring–quadriceps strength ratio at different movement velocities in healthy young adults. SPORT SCIENCES FOR HEALTH, 21(4), 2795-2804 [10.1007/s11332-025-01483-x]. Dettaglio
Hertz, D., Tanay, M., Tofthagen, C., Rossi, E., Bernasconi, D., Sheffield, K., et al. (2025). Patient-reported strategies for prevention and treatment of chemotherapy-induced peripheral neuropathy. SUPPORTIVE CARE IN CANCER, 33(2) [10.1007/s00520-025-09190-6]. Dettaglio
Velasco, R., Argyriou, A., Cornblath, D., Bruna, P., Alberti, P., Rossi, E., et al. (2024). Repurposing chemotherapy-induced peripheral neuropathy grading. EUROPEAN JOURNAL OF NEUROLOGY, 31(12 (December 2024)) [10.1111/ene.16457]. Dettaglio
Soria, A., Graziano, F., Ghilardi, G., Lapadula, G., Gasperina, D., Benatti, S., et al. (2024). Monoclonal antibodies against SARS-CoV-2 to prevent COVID-19 worsening in a large multicenter cohort. HELIYON, 10(16) [10.1016/j.heliyon.2024.e36102]. Dettaglio